Aushon BioSystems Inc. is a small, privately owned corporation applying advanced engineering and systems-engineering approaches to the challenges of developing life science markets. Aushon is leveraging its advanced engineering capabilities to develop a set of products and capabilities at the confluence of life science and advanced engineering.
The human genome contains approximately 30,000 genes; the human proteome approximately 1,000,000 proteins. Most animals and plants of commercial interest have genomes and proteomes of comparable size. One of the keys to future discoveries in life-science, pharmacology and diagnostics is the ability to process genomic and proteomic assays in massively parallel formats; both will be required to unravel the complexities of biological systems and to enable genome-based/proteome-based diagnostics and drug discovery. Only oligo and cDNA arrays have been produced in high-volume formats to date, but at prices that are prohibitively high for many potential users.
